Malawi recommended COVID-19 vaccines for adults aged ≥18 years in March 2021. We assessed factors associated with receiving COVID-19 vaccines in Malawi as part of a telephone-based syndromic surveillance survey. We conducted telephone-based syndromic surveillance surveys with questions on COVID-19 vaccine receipt among adults (≥18 years old) upon verbal consent from July 2021 to April 2022. We used random digit dialing to select mobile phone numbers and employed electronic data collection forms on secure tablets. Survey questions included whether the respondent had received at least one dose of a COVID-19 vaccine. We used multivariable analysis to identify factors associated with COVID-19 vaccine receipt. Of the 51,577 participants enrolled; 65.7% were male. Males were less likely to receive the COVID-19 vaccine than females (AOR 0.83, 95% CI 0.80–0.86). Compared to those aged 18–24 years, older age had increased odds of vaccine receipt: 25–34 years (AOR 1.32, 95% CI 1.24–1.40), 35–44 years (AOR 2.00, 95% CI 1.88–2.13), 45–54 years (AOR 3.02, 95% CI 2.82–3.24), 55–64 years (AOR 3.24, 95% CI 2.93–3.57) and 65 years+ (AOR 3.98, 95% CI 3.52–4.49). Respondents without formal education were less likely to receive vaccination compared to those with primary (AOR 1.30, 95% CI 1.14–1.48), secondary (AOR 1.76, 95% CI 1.55–2.01), and tertiary (AOR 3.37, 95% CI 2.95–3.86) education. Respondents who thought COVID-19 vaccines were unsafe were less likely to receive vaccination than those who thought it was very safe (AOR 0.26, 95% CI 0.25–0.28). Residents of the Central and Southern regions had reduced odds of vaccine receipt compared to those in the North (AORs 0.79, (95% CI 0.74–0.84) and 0.55, (95% CI 0.52–0.58) respectively). Radio (72.6%), health facilities (52.1%), and social media (16.0%) were the more common self-reported sources of COVID-19 vaccine information. COVID-19 vaccine receipt is associated with gender, age, education, and residence. It is important to consider these factors when implementing COVID-19 vaccination programs.
Explore Related Resources
Malawi landscape
Poster
Twenty-Four-Month Survival Among Patients with Cryptococcal Antigenemia Enrolled in Malawi’s Advanced HIV Disease Program: A Retrospective Cohort Study
Published August 2026
We assessed 24-month survival and factors associated with mortality among AHD clients with cryptococcal antigenemia enrolled in Malawi’s AHD program.
View Resource
Topics:
Advanced HIV Disease (AHD)
Countries:
Malawi
Journal Articles
Clinical Impact and Cost-Effectiveness of Improving Access to Cryptococcal Meningitis Diagnostics and Treatment in Malawi
Published May 2026
Abstract Background Cryptococcal meningitis (CM) causes 13%–20% of deaths among people living with HIV (PLHIV) globally. We examined the cost-effectiveness of improving access to CM diagnostics and treatment among PLHIV initiating HIV care with a positive serum cryptococcal antigen (CrAg) test in Malawi. Methods We used the CEPAC-I model to simulate (1) Current care (CM treatment if […]
View Resource
Topics:
HIV
Countries:
Malawi
Journal Articles
Patient tracking and retention with Malawi’s electronic medical records system in antiretroviral treatment clinics
Published May 2026
A 2026 study in Malawi shows that electronic medical record tools can improve HIV patient retention by quickly identifying missed appointments and enabling timely follow-up, strengthening continuity of care.
View Resource
Topics:
Digital Health
Countries:
Malawi